Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management

Published:2022-10-09 Issue:12 Volume:42 Page:1257-1287
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Allemailem Khaled S.¹,Alsahli Mohammed A¹,Almatroudi Ahmad¹,Alrumaihi Faris¹,Alkhaleefah Fahd Khaleefah²,Rahmani Arshad Husain¹,Khan Amjad Ali³^ORCID

Affiliation:

1. Department of Medical Laboratories, College of Applied Medical Sciences Qassim University Buraydah Saudi Arabia

2. Department of Laboratory and Blood Bank Al Rass General Hospital Al Rass Saudi Arabia

3. Department of Basic Health Sciences College of Applied Medical Sciences Qassim University Buraydah Saudi Arabia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12366

Reference231 articles.

1. Conditional Control of CRISPR/Cas9 Function

2. Rewriting a genome

3. Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA

4. Development and Applications of CRISPR-Cas9 for Genome Engineering

5. Multiplex Genome Engineering Using CRISPR/Cas Systems

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy;Current Protein & Peptide Science;2024-12

2. Strategies and delivery systems for cell-based therapy in autoimmunity;Frontiers in Drug Delivery;2024-08-08

3. Delivery of nucleic acid based genome editing platforms via lipid nanoparticles: Clinical applications;Advanced Drug Delivery Reviews;2024-08

4. A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9;Nano Select;2024-07-18

5. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment;Nanotechnology;2024-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3